Admerus Biosciences Profile
Key Indicators
- Authorised Capital ₹ 14.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 11.93 Cr
as on 11-12-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.95 Cr
as on 11-12-2024
- Revenue 5105.45%
(FY 2020)
- Profit -7240.23%
(FY 2020)
- Ebitda -1391.70%
(FY 2020)
- Net Worth 155.66%
(FY 2020)
- Total Assets 15.46%
(FY 2020)
About Admerus Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.00 Cr and a paid-up capital of Rs 11.93 Cr.
The company currently has active open charges totaling ₹20.95 Cr.
The Key Managerial Personnel (KMP) at Admerus Biosciences Private Limited India is Dudekulla Alima as COMPANY SECRETARY. Pattabhi Koppineedi, China Koppineedi, and Jayasree Koppineedi serve as directors at the Company.
- CIN/LLPIN
U74900TG2015PTC133392
- Company No.
133392
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jul 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Admerus Biosciences?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pattabhi Koppineedi  | Managing Director | 09-Jul-2015 | Current |
| Dudekulla Alima | Company Secretary | 23-Jul-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| China Koppineedi | Director | 09-Jul-2015 | Current |
| Jayasree Koppineedi | Director | 07-Oct-2017 | Current |
Financial Performance of Admerus Biosciences.
Admerus Biosciences Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 5105.45% increase. The company also saw a substantial fall in profitability, with a 7240.23% decrease in profit. The company's net worth Soared by an impressive increase of 155.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Admerus Biosciences?
In 2021, Admerus Biosciences had a promoter holding of 78.18% and a public holding of 21.82%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Organic Harvests Private LimitedActive 12 years 5 monthsPattabhi Koppineedi and China Koppineedi are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 17 Nov 2017 | ₹20.95 Cr | Open |
How Many Employees Work at Admerus Biosciences?
Admerus Biosciences has a workforce of 19 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Admerus Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Admerus Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
